New Delhi: India has received requests for the supply of Covid-19 vaccines from 22 countries so far these have already been supplied to 15 countries, Union Health Minister Harsh Vardhan said on Friday.
Replying to queries during question hour in Lok Sabha, the minister said the vaccines have been supplied both as grant assistance and contract doses.
Also Read: Covid-19: India fought pandemic much better than other nations, says Dr. Harsh Vardhan
"We have received requests for vaccine supply from 22 nations so far. Out of these, supply has already been made to 15 nations as grant assistance as well as contract doses. As of February 2, a total of 56 lakh doses has been given as grant assistance and 105 lakh as contracts doses," the minister said.
The government has given emergency use authorization to two vaccines-- Covishield and Covaxin.
The minister gave the reply amid protest by opposition members over their demand for the repeal of three new farm laws.
Also Read: Covid-19 patients to be given 2 doses of Pfizer vaccine in 21-28 day gap: WHO
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!